Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Varner

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Cancer Cell|June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progressionMichael C Schmid, Christie J Avraamides, Holly C Dippold, et al.
Nature Communications|December 21, 2018
Integrin CD11b activation drives anti-tumor innate immunityMichael C Schmid, Samia Q Khan, Megan M Kaneda, et al.
Cancer Discovery|December 31, 2015
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas CancerAndrew J Gunderson, Megan M Kaneda, Takahiro Tsujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2021
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide responseJie Li, Megan M Kaneda, Jun Ma, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Expert opinion on burning questions in cancer myeloid cell biologyJennifer L Guerriero, Miriam Merad, Florent Ginhoux, et al.
Oncogene|April 11, 2019
MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophagesMichele L Babicky, Megan M Harper, Jeffery Chakedis, et al.
Nature|November 8, 2016
PI3Kγ is a molecular switch that controls immune suppressionMegan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
Nature|December 16, 2016
Corrigendum: PI3Kγ is a molecular switch that controls immune suppressionMegan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
Science Translational Medicine|July 3, 2024
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infectionsRyan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Cancer Cell|June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progressionMichael C Schmid, Christie J Avraamides, Holly C Dippold, et al.
Nature Communications|December 21, 2018
Integrin CD11b activation drives anti-tumor innate immunityMichael C Schmid, Samia Q Khan, Megan M Kaneda, et al.
Cancer Discovery|December 31, 2015
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas CancerAndrew J Gunderson, Megan M Kaneda, Takahiro Tsujikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2021
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide responseJie Li, Megan M Kaneda, Jun Ma, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Expert opinion on burning questions in cancer myeloid cell biologyJennifer L Guerriero, Miriam Merad, Florent Ginhoux, et al.
Oncogene|April 11, 2019
MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophagesMichele L Babicky, Megan M Harper, Jeffery Chakedis, et al.
Nature|November 8, 2016
PI3Kγ is a molecular switch that controls immune suppressionMegan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
Nature|December 16, 2016
Corrigendum: PI3Kγ is a molecular switch that controls immune suppressionMegan M Kaneda, Karen S Messer, Natacha Ralainirina, et al.
Science Translational Medicine|July 3, 2024
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infectionsRyan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai, et al.
Pageof 5